Friday, April 05, 2013

Xconomy Boulder/Denver: 'Crash Course for Colorado Biotech Entrepreneurs Coming April 18'

 Quoting from yesterday's posting:

"Who said startup accelerators and boot camps were just for software companies?

The Colorado BioScience Association will host a two-day 'BioBoot Camp' in Denver on April 18 and 19. The event is intended to help scientists and entrepreneurs who are doing promising research understand how to commercialize their discoveries and build companies."

Link to Xconomy Boulder/Denver

Note: applications are due today (extended from April 3), Friday, April 5... details

Application pdf

More information:

DAY ONE: Business Focused Sessions

Overview: "So you want to start a life science company?" 
Company Formation: "Nuts and bolts of starting a business"
Understanding the Technology Transfer Operation & Funding Opportunities
Intellectual Property: "Protecting your technology"
Transitioning your Management Team
Compensating your Management Team
State & Community Resources
Company Valuation Part I: Company Perspective/II: Investor Perspective
Dilutive Funding Panel: Angel, Venture Capital and Strategic Investors 
Getting the Deal Done: Diligence and term sheets

DAY TWO: R&D Focused Sessions
Breakfast
Track I & II
       Drugs and Vaccines: Preclinical Development/ Regulatory Affairs
       Medical Device & Diagnostic:  Development Part / Regulatory Affairs
Clinical Development Overview
Reimbursement: Drugs, Vaccines, Devices & Diagnostics

Presenters Include:
Clay Anselmo, Reglera
Ken Dropiewski, Prime-Core Executive Search
Brenda Fielding, Regulus
April Giles, Colorado BioScience Association
Sonya Guram, CO Office of Economic Development & International Trade
Brad Hattenbach, Dorsey & Whitney
Greg Miknis, C2D2 
Sean Moriarty, Tolmar
Terry Opgenorth, Ph.D., CSU Ventures
Tom Smerdon
, CU Technology Transfer Office 
Patty Telgener, Emerson Consultants 
Jonathan Thorne, Edgeport Surgical
Will Vaughan, Technology Transfer Colorado School of Mines
Michael Weiner, Dorsey & Whitney
Tim Worrall, Dorsey & Whitney

No comments:

Post a Comment